• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Rare Cause of Pulmonary Hypertension in Humans Has Been Identified in Dogs

June 16, 2016
Laurie Anne Walden, DVM, ELS

The first report of pulmonary veno-occlusive disease (PVOD) in dogs has been published.

The first report of pulmonary veno-occlusive disease (PVOD) in dogs has been published in Veterinary Pathology. PVOD is a rare cause of pulmonary hypertension in humans, with an estimated incidence of 0.1 to 0.2 cases per million people.

In humans, PVOD is a form of pulmonary arterial hypertension that causes clinically severe disease. It is characterized by occlusion of small pulmonary veins and venules, resulting in upstream congestion of alveolar capillaries. Lesions within the pulmonary artery are also common. The cause in humans is not entirely clear, but toxins, viral infection, genetics, and immune-mediated causes have been proposed. The only treatment is lung transplantation. Without transplantation, the average survival time is 2 years after diagnosis.

Advertisement

The study authors identified lesions similar to those of human PVOD in lung samples from 11 dogs that died of respiratory disease. The dogs were of various breeds and geographic locations (Michigan, Massachusetts, California, and the United Kingdom). The most common presenting signs were acute respiratory distress, cough, and inappetence. Five of the dogs were euthanized soon after presentation (within hours, according to the authors) because of the rapid progression of their disease. The longest survival time before euthanasia was 6 months.

On gross pathology, the dogs’ lungs were edematous and consolidated, with many foci of congestion. Histopathologic examination revealed occlusive remodeling of small pulmonary veins, alveolar capillary congestion, foci of pulmonary capillary hemangiomatosis, and increased numbers of alveolar hemosiderophages—findings that are all typical of PVOD in humans. Six of the dogs also had pulmonary arterial remodeling. Transmission electron microscopy and immunohistochemical labeling showed that the occlusion in the pulmonary veins was partially composed of smooth muscle cells.

The dogs in this study were all adults (average age, 10.5 years). In contrast, PVOD in humans is more prevalent in children and young adults, although it also occurs in older adults. The clinical progression in the dogs was rapid; in most human patients the disease is reported to progress more slowly. The authors suggest that the incidence of PVOD could be higher in dogs than in people, speculating that many canine cases have gone undiagnosed. The cause of PVOD in dogs is unknown.

A mouse model for investigating PVOD in the laboratory has been developed. The authors write that canine PVOD could be a spontaneous model for research into the pathogenesis of the disease. “PVOD is a poorly understood disease not just because it’s so rare, but also because there’ve been no other animals known to have the disease,” said lead author Kurt Williams, of the College of Veterinary Medicine at Michigan State University, in an interview in MSUToday. “Our finding changes things.”

Dr. Laurie Anne Walden received her doctorate in veterinary medicine from North Carolina State University in 1994. After an internship at Auburn University College of Veterinary Medicine, she returned to North Carolina, where she has been in companion animal general practice for over 20 years. Dr. Walden is also a board-certified Editor in the Life Sciences and owner of Walden Medical Writing.


Advertisement

Latest News

New technology and products for veterinary genealogy

Reduce your veterinary teams’ stress with financial wellness

Cuban crocodiles receive surgery to extract foreign items

Purina Pro Plan Veterinary Diets joins forces with AVMF

View More Latest News
Advertisement